Analysis of the therapeutic effect of sodium copper chlorophyllin tablet in treating 60 cases of leukopenia

Gao Feng; Hu Xiu-fen

doi:10.1007/BF02835789

Your Location：

Home >

Browse articles >

Analysis of the therapeutic effect of sodium copper chlorophyllin tablet in treating 60 cases of leukopenia

Updated：2021-08-27

- Analysis of the therapeutic effect of sodium copper chlorophyllin tablet in treating 60 cases of leukopenia
- Chinese Journal of Integrative Medicine Vol. 11, Issue 4, Pages: 279-282(2005)
- Affiliations：
  
  1. Department of Internal Medicine, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology,Wuhan
  2. Department of Pediatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology,China
- Author bio：
- Funds：
- DOI：10.1007/BF02835789
  CLC：
- Published：2005，
Scan for full text
Feng, G., Xiu-fen, H. Analysis of the therapeutic effect of sodium copper chlorophyllin tablet in treating 60 cases of leukopenia., Chin. J. Integr. Med. 11, 279–282 (2005). https://doi.org/10.1007/BF02835789

Gao Feng, Hu Xiu-fen. Analysis of the therapeutic effect of sodium copper chlorophyllin tablet in treating 60 cases of leukopenia. [J]. Chinese Journal of Integrative Medicine 11(4):279-282(2005)
Feng, G., Xiu-fen, H. Analysis of the therapeutic effect of sodium copper chlorophyllin tablet in treating 60 cases of leukopenia., Chin. J. Integr. Med. 11, 279–282 (2005). https://doi.org/10.1007/BF02835789 DOI：

Gao Feng, Hu Xiu-fen. Analysis of the therapeutic effect of sodium copper chlorophyllin tablet in treating 60 cases of leukopenia. [J]. Chinese Journal of Integrative Medicine 11(4):279-282(2005) DOI： 10.1007/BF02835789.

摘要

Objective: To evaluate the efficacy and safety of sodium copper chlorophyllin (trademarked as “Yebaike Tablet which is abbreviated as YBK in treating leukopenia.Methods: One hundred and five patients with leukopenia caused by various factors were randomized into 3 groups. The 60 patients in the YBK group took orally YBK Tablets at the dose of 40 mg

three times per day

the 30 patients in the leucogen group were treated with Leucogen Tablets at the dose of 20 mg

three times per day

and the 15 patients in the placebo group were administered with vitamin C tablets 100 mg

three times per day. All the subjects were treated for 1 month. The change of peripheral leucocytes count after treatment and adverse drug reaction that occurred in patients were studied.Results: In the 60 patients treated with YBK

the treatment proved to be markedly effective in 34 cases

effective in 17 and ineffective in 9

the total effective rate being 85%

which was significantly higher than that in the placebo group (26.7%

P<0.01) and similar to that in the leucogen group (83. 3%

P>0.05). No adverse reaction was found in the treatment course.Conclusion: YBK can be used in the treatment of leukopenia caused by various factors

satisfactory in efficacy and safe in use.

Abstract

three times per day

the 30 patients in the leucogen group were treated with Leucogen Tablets at the dose of 20 mg

three times per day

and the 15 patients in the placebo group were administered with vitamin C tablets 100 mg

the treatment proved to be markedly effective in 34 cases

effective in 17 and ineffective in 9

the total effective rate being 85%

which was significantly higher than that in the placebo group (26.7%

P<0.01) and similar to that in the leucogen group (83. 3%

P>0.05). No adverse reaction was found in the treatment course.Conclusion: YBK can be used in the treatment of leukopenia caused by various factors

satisfactory in efficacy and safe in use.

关键词

leukopeniasodium copper chlorophyllin

Keywords

leukopeniasodium copper chlorophyllin

references

Hao JP, Yan WS. Effect of sodium copper chlorophyllin tablet in treating leukopenia induced by anti-thyroid drugs. J Pract Med 2004; 20(2): 205.

He XL. Clinical observation of sodium copper chlorophyllin tablet in treating 54 cases of neutropenia in children. J Chin Phys 2004; 6(2): 272.

Fang GQ, Zhu AP, Xu Y. Effect of sodium copper chlorophyllin in treating leukopenia. Anhui Med J 2001;22(5): 58–59.

Zhang ZN, editor. Criteria for the diagnosis and efficacy evaluation of hematologic diseases. 2nd ed. Beijing: Science Press, 1998: 174–176.

Luo SK, Hong WD, editors. Hematopathy and diseases of hematopoietic system. Beijing: Scientific and Technologic Literature Publishing House, 1999: 66–68.

Wang ZY, Gao ZT, Liu SQ. New progress on application of sodium copper chlorophyllin and its derivative in medicine and pharmacy. Chongqing J Chin Tradit Herb Drugs 1999; 40(10): 167–172.

Su GL, Shi L. Pharmadynamic study and clinical observation of quickly released gastric drug sodium copper chlorophyllin tablets. Lishizhen Med Meteria Medica Res 2001: 12(7): 623–624.

Zhu LQ, Shen NC. Experimental study of sodium copper chlorophyllin in protecting liver from acute and chronic injury. Chin J Pharm 1990; 21(10): 442–445.

FULL TEXT LINK

More>

Views

420

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Effects of sodium copper chlorophyllin on mesenchymal stem cell function in aplastic anemia mice

Short-Term effects of cinobufagin in the treatment of middle and advanced malignant tumors

Clinical and experimental study on bushen cong-er tablet in treating sensorineural hearing loss) tablet in treating sensorineural hearing loss

Clinical study on treatment of chemotherapy or radiotherapy induced leukopenia with Fuzheng Compound ( ))

Related Author

No data

Related Institution

Research Institute of Hematopathy, the First Affiliated Hospital, Zhejiang Chinese Medical University

Tongde Hospital of Zhejiang Province

Department of Oncology, the First Affiliated Hospital, Henan Medical University

ENT Department, Nankai Hospital

The School of Oncology, Beijing Medical University

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰